New Key Statistics Module, Z-Score and F-Score
NAS:RPRX Key Ratios
Market Cap $ M | 12,659.04 |
Enterprise Value $ M | 17,405.74 |
P/E(ttm) | 15.86 |
PE Ratio without NRI | 25.89 |
Forward PE Ratio | 9.32 |
Price/Book | 1.95 |
Price/Sales | 7.55 |
Price/Free Cash Flow | 6.48 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.75 |
Revenue (TTM) $ M | 2,238.00 |
EPS (TTM) $ | 1.77 |
Beneish M-Score | -3.45 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -23.00 |
y-y EBITDA Growth Rate % | 135.00 |
EV-to-EBIT | 12.69 |
EV-to-EBITDA | 12.69 |
PEG | -- |
Shares Outstanding M | 450.98 |
Net Margin (%) | 35.69 |
Operating Margin % | 41.97 |
Pre-tax Margin (%) | 53.01 |
Quick Ratio | 12.52 |
Current Ratio | 12.52 |
ROA % (ttm) | 4.84 |
ROE % (ttm) | 12.72 |
ROIC % (ttm) | 6.31 |
Dividend Yield % | 2.88 |
Altman Z-Score | 1.95 |
RPRX Number of Guru Trades
RPRX Volume of Guru Trades
Gurus Latest Trades with NAS:RPRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RPRX is held by these investors
Total 1
Royalty Pharma PLC Insider Transactions
No Available Data
News about NAS:RPRX
Total 0- 1